Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Increased mortality in patients with differentiated thyroid cancer associated with Graves' disease.

Pellegriti G, Mannarino C, Russo M, Terranova R, Marturano I, Vigneri R, Belfiore A.

J Clin Endocrinol Metab. 2013 Mar;98(3):1014-21. doi: 10.1210/jc.2012-2843. Epub 2013 Jan 24.

PMID:
23348395
2.

[Incidental differentiated thyroid carcinoma is less prevalent in Graves' disease than in multinodular goiter].

Pascual Corrales E, Príncipe RM, Laguna Muro S, Martínez Regueira F, Alcalde Navarrete JM, Guillén Grima F, Galofré JC.

Endocrinol Nutr. 2012 Mar;59(3):169-73. doi: 10.1016/j.endonu.2011.12.004. Epub 2012 Feb 9. Spanish.

PMID:
22325789
3.

Incidental papillary thyroid carcinoma: clinical characteristics and prognostic factors among patients with Graves' disease and euthyroid goiter, Cleveland Clinic experience.

Ergin AB, Saralaya S, Olansky L.

Am J Otolaryngol. 2014 Nov-Dec;35(6):784-90. doi: 10.1016/j.amjoto.2014.04.013. Epub 2014 May 6.

PMID:
25128909
4.

Outcome of differentiated thyroid cancer in Graves' patients.

Pellegriti G, Belfiore A, Giuffrida D, Lupo L, Vigneri R.

J Clin Endocrinol Metab. 1998 Aug;83(8):2805-9.

PMID:
9709951
5.

Thyroid carcinoma in patients with Graves' disease: an institutional experience.

Wei S, Baloch ZW, LiVolsi VA.

Endocr Pathol. 2015 Mar;26(1):48-53. doi: 10.1007/s12022-014-9343-6.

PMID:
25332114
6.

Prognostic factors for differentiated thyroid carcinoma and review of the literature.

Zhao Y, Zhang Y, Liu XJ, Shi BY.

Tumori. 2012 Mar-Apr;98(2):233-7. doi: 10.1700/1088.11935. Review.

PMID:
22677990
7.

Higher incidence of tall cell variant of papillary thyroid carcinoma in Graves' Disease.

Boutzios G, Vasileiadis I, Zapanti E, Charitoudis G, Karakostas E, Ieromonachou P, Karatzas T.

Thyroid. 2014 Feb;24(2):347-54. doi: 10.1089/thy.2013.0133. Epub 2013 Sep 11.

PMID:
23786233
8.

Does Graves' disease or thyrotoxicosis affect the prognosis of thyroid cancer.

Hales IB, McElduff A, Crummer P, Clifton-Bligh P, Delbridge L, Hoschl R, Poole A, Reeve TS, Wilmshurst E, Wiseman J.

J Clin Endocrinol Metab. 1992 Sep;75(3):886-9.

PMID:
1517381
9.

Differentiated thyroid carcinoma: presentation and follow-up in children and adolescents.

Papendieck P, Gruñeiro-Papendieck L, Venara M, Acha O, Maglio S, Bergadá I, Chiesa A.

J Pediatr Endocrinol Metab. 2011;24(9-10):743-8.

PMID:
22145467
10.

Prognostic factors and follow-up of patients with differentiated thyroid carcinoma with false negative or nondiagnostic FNAC before surgery. Comparison with a control group.

García-Pascual L, Balsells M, Fabbi M, Pozo CD, Valverde MT, Casalots J, González-González JM, Veloso E, Anglada-Barceló J.

Endocrine. 2011 Dec;40(3):423-31. doi: 10.1007/s12020-011-9479-9. Epub 2011 May 4.

PMID:
21541652
11.

[Hyperthyroidism and thyroid carcinoma].

Sechanov T, Mendizov I.

Khirurgiia (Sofiia). 1987;40(5):69-75. Bulgarian. No abstract available.

PMID:
3430989
12.

Papillary thyroid carcinoma in an adolescent girl with graves' disease.

Gesing J, Pfaeffle R, Christiansen H, Keller A, Lincke T, Lamesch P, Sabri O, Kiess W.

Klin Padiatr. 2014 Nov;226(6-7):379-81. doi: 10.1055/s-0034-1387731. Epub 2014 Nov 28. No abstract available.

PMID:
25431871
13.

Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this question.

Elisei R, Molinaro E, Agate L, Bottici V, Masserini L, Ceccarelli C, Lippi F, Grasso L, Basolo F, Bevilacqua G, Miccoli P, Di Coscio G, Vitti P, Pacini F, Pinchera A.

J Clin Endocrinol Metab. 2010 Apr;95(4):1516-27. doi: 10.1210/jc.2009-1536. Epub 2010 Feb 15.

PMID:
20156922
14.

Small carcinomas of the thyroid. A long-term follow-up of 867 patients.

Noguchi S, Yamashita H, Murakami N, Nakayama I, Toda M, Kawamoto H.

Arch Surg. 1996 Feb;131(2):187-91.

PMID:
8611077
15.

Thyroid nodules and thyroid cancer in Graves' disease.

Tam AA, Kaya C, Kılıç FB, Ersoy R, Çakır B.

Arq Bras Endocrinol Metabol. 2014 Dec;58(9):933-8. doi: 10.1590/0004-2730000003569.

16.

Recurrent disease in juvenile differentiated thyroid carcinoma: prognostic factors, treatments, and outcomes.

Mihailovic J, Nikoletic K, Srbovan D.

J Nucl Med. 2014 May;55(5):710-7. doi: 10.2967/jnumed.113.130450. Epub 2014 Apr 10.

17.

Total thyroidectomy as primary definitive treatment for Graves' hyperthyroidism.

Snyder S, Govednik C, Lairmore T, Jiang DS, Song J.

Am Surg. 2013 Dec;79(12):1283-8.

PMID:
24351357
18.

Differentiated thyroid cancer in a Swedish county--long-term results and quality of life.

Malterling RR, Andersson RE, Falkmer S, Falkmer U, Niléhn E, Järhult J.

Acta Oncol. 2010 May;49(4):454-9. doi: 10.3109/02841860903544600.

PMID:
20092427
19.

The efficacy of thyroidectomy for Graves' disease: A meta-analysis.

Palit TK, Miller CC 3rd, Miltenburg DM.

J Surg Res. 2000 May 15;90(2):161-5.

PMID:
10792958
20.

Prognosis of small thyroid cancer in patients with Graves' disease.

Kikuchi S, Noguchi S, Yamashita H, Uchino S, Kawamoto H.

Br J Surg. 2006 Apr;93(4):434-9.

PMID:
16523447

Supplemental Content

Support Center